Grzegorz Domek | Polymerase Chain Reaction | Research Excellence Award

Published on by Medical Lab Scientist

Research Excellence Award

Grzegorz Domek
Kazimierz Wielki University, Poland
Grzegorz Domek
Affiliation Kazimierz Wielki University
Country Poland
Scopus ID 37016937700
Documents 33
Citations 289
h-index 11
Subject Area Polymerase Chain Reaction
Event Medical Lab Scientist Awards
ORCID 0000-0003-3566-9110

The Research Excellence Award recognizes distinguished scholarly achievements and sustained academic contributions within the field of medical laboratory sciences and molecular diagnostics. Grzegorz Domek of Kazimierz Wielki University has demonstrated notable research involvement in Polymerase Chain Reaction methodologies and related biomedical investigations. His academic profile reflects consistent scientific engagement through peer-reviewed publications, citation impact, and interdisciplinary laboratory collaborations.[1]

Abstract

This article presents an academic overview of Grzegorz Domek and his scholarly activities associated with Polymerase Chain Reaction research and laboratory-based biomedical investigations. Through a combination of publication output, citation metrics, and interdisciplinary scientific engagement, the researcher has contributed to the advancement of molecular diagnostics and laboratory methodologies. The profile further highlights the relevance of his work within contemporary medical laboratory science and discusses the basis for recognition through the Research Excellence Award.[2]

Keywords

Polymerase Chain Reaction, Molecular Diagnostics, Medical Laboratory Science, Biomedical Research, DNA Amplification, Clinical Diagnostics, Laboratory Medicine, Research Excellence Award, Molecular Biology, Academic Recognition

Introduction

Polymerase Chain Reaction (PCR) technologies continue to play a critical role in molecular biology, infectious disease diagnostics, genetic testing, and biomedical research. The development and application of PCR-based methodologies have significantly transformed clinical laboratory practices by enabling rapid detection and analysis of nucleic acid sequences.[3]

Research Profile

Grzegorz Domek is affiliated with Kazimierz Wielki University in Poland and maintains an active academic presence within the international scientific community. According to indexed bibliometric databases, the researcher has produced 33 scholarly documents with a cumulative citation count of 289 and an h-index of 11. These indicators reflect sustained participation in peer-reviewed scientific communication and research dissemination.[1]

Research Contributions

The scholarly contributions associated with Grzegorz Domek include research related to molecular diagnostics, nucleic acid amplification techniques, and biomedical laboratory procedures. PCR methodologies remain central to numerous applications involving pathogen detection, genetic analysis, and laboratory quality assessment.[4]

Publications

The publication record indexed under the researcher’s Scopus profile includes scholarly articles associated with molecular biology, diagnostic medicine, and laboratory science. The documented research output demonstrates continuity in scientific publication and peer-reviewed academic dissemination.[1]

Research Impact

Research impact may be evaluated through publication metrics, citation performance, interdisciplinary relevance, and contribution to laboratory-based scientific knowledge. With 289 citations and an h-index of 11, the researcher demonstrates measurable academic visibility within the field of molecular diagnostics and biomedical laboratory science.[1]

Award Suitability

The Research Excellence Award within the Medical Lab Scientist Awards framework recognizes scholarly dedication, publication consistency, scientific influence, and contribution to laboratory science advancement. Grzegorz Domek’s documented publication profile, citation metrics, and molecular diagnostics research activities collectively align with the academic criteria commonly associated with scientific recognition programs.[5]

Conclusion

Grzegorz Domek’s academic profile reflects sustained scholarly engagement within the field of Polymerase Chain Reaction and laboratory-oriented biomedical research. Through peer-reviewed publications, citation performance, and interdisciplinary scientific participation, the researcher has contributed to the ongoing development of molecular diagnostics and laboratory science methodologies.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Grzegorz Domek, Author ID 37016937700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=37016937700
  2. Bustin, S. A., et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry.https://doi.org/10.1373/clinchem.2008.112797
  3. Nature Protocols. (2006). PCR Protocols and Molecular Amplification Techniques. https://doi.org/10.1038/nprot.2006.236
  4. Acta Mechanica et Automatica. (2022). Influence of Extruder Plasticizing Systems on the Selected Properties of PLA/Graphite Composite. https://doi.org/10.2478/ama-2022-0038
  5. Medical Lab Scientist Awards. (n.d.). Research Excellence Award program and scientific recognition criteria. https://medicallabscientist.com/

Heming Li | Molecular Biology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Heming Li | Molecular Biology | Research Excellence Award

Doctor | The first hospital of China Medical University | China

Dr. Heming Li is an oncology clinician-scientist whose research has generated 1,045 citations across 37 scientific documents with an h-index of 17, reflecting a sustained impact on translational cancer science. His work centers on liquid biopsy innovations, particularly circulating tumor cells (CTCs), tumor invasion and metastasis, and immunotherapy biomarkers in lung, gastric, and hepatobiliary cancers. Dr. Li is recognized for pioneering one of China’s earliest and most sensitive cell-surface vimentin (CSV)–based CTC detection platforms, integrating negative and positive enrichment to enhance diagnostic accuracy, reduce costs, and enable real-time monitoring of tumor evolution. His research spans EMT regulation, immune escape, metabolic reprogramming, and multi-omics characterization of metastatic pathways, leading to first-author and corresponding-author publications in high-impact journals such as The Lancet, Journal of Hematology & Oncology, Journal of Experimental & Clinical Cancer Research, Molecular Cancer, Cancer Letters, and Cell Death & Disease. He has elucidated mechanisms including IGF-IR signaling, KDM4A/STAT3-driven tumor progression, ICAM-1-mediated microenvironmental adaptation, and PD-L1 expression on CSV⁺ CTCs as a prognostic marker in gastric cancer. His recent studies have also advanced understanding of FGL1 as an immune checkpoint target and the biological significance of TROP2 in cancer therapeutics. As principal investigator, he has secured major national and provincial funding, including NSFC General and Young Programs, to study CTC-based biomarkers, immunotherapy prediction models, and metastasis-driving pathways. Through sustained contributions across liquid biopsy technology, molecular oncology, and clinically actionable biomarker development, Dr. Li has established a leading research profile shaping the future of precision cancer care.

Profile: Scopus  

Featured Publications

Semiha Yenigun | Biochemistry | Editorial Board Member

Published on by Medical Lab Scientist

Dr. Semiha Yenigun |  Biochemistry | Editorial Board Member

Doctor | University of Ondokuz Mayis | Turkey

Dr. Semiha Yenigün is a distinguished researcher in the field of bioactive natural compounds and medicinal chemistry, with a Ph.D. in Chemistry from Ondokuz Mayıs University, Turkey (2023). Her research primarily focuses on phytochemical analysis, enzyme inhibition, antioxidant mechanisms, and molecular docking studies of plant-derived compounds, particularly from the Nepeta genus and other medicinal species. Dr. Yenigün has extensively explored bioactivity-guided fractionation, DNA protection assays, and in silico molecular dynamics and MM-PBSA analyses to evaluate structure–activity relationships of bioactive molecules. She has co-authored numerous publications in high-impact journals such as the Journal of Biomolecular Structure & Dynamics, ChemistrySelect, and Journal of the Indian Chemical Society. Her studies integrate computational chemistry and experimental biochemistry to identify potential therapeutic agents with antioxidant, antimicrobial, and enzyme inhibitory properties. Dr. Yenigün has contributed significantly to TÜBİTAK-funded projects including investigations on Nepeta baytopii and Elaeagnus umbellata, emphasizing the biotechnological production and characterization of triterpenoids and other phytochemicals. Her scholarly output demonstrates a strong command of molecular modeling, pharmacokinetic analysis, and bioinformatics applications in natural product chemistry, establishing her as an emerging expert in structure-based drug discovery and natural compound bioactivity evaluation.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications

Bechan Sharma | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Bechan Sharma |  Biochemistry | Best Researcher Award

Professor | University of Allahabad | India

Dr. Bechan Indrajit Sharma is a highly accomplished scholar and researcher associated with the University of Allahabad, Prayagraj, India. Over the course of his distinguished career, he has made significant contributions to the fields of biochemistry, molecular biology, and environmental toxicology. His extensive research output includes 171 published documents, reflecting his deep engagement with scientific inquiry and academic excellence. With an impressive total of 5,328 citations  and an h-index of 37, Dr. Sharma has established himself as an influential figure in his area of expertise. His research has not only advanced understanding in critical areas of biological sciences but also addressed important environmental and health-related challenges. Through collaborations with over 300 co-authors, he has fostered interdisciplinary and cross-institutional partnerships, contributing to the global scientific dialogue. Dr. Sharma’s academic journey at the University of Allahabad is marked by his dedication to teaching, mentoring, and guiding young researchers toward innovation and scientific rigor. His work demonstrates a commitment to high-impact research that bridges theory and application, benefiting both academia and society. Known for his meticulous approach and passion for discovery, Dr. Sharma continues to inspire future generations of scientists through his research excellence and leadership in academia. His scholarly achievements and influence make him a prominent voice in the scientific community, reflecting a career devoted to advancing knowledge, fostering collaboration, and promoting sustainable scientific growth on both national and international levels.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications